CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q2 2016. The put-call ratio across all filers is 8.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,784,000 | +49.7% | 1,200,000 | 0.0% | 0.12% | +41.7% |
| Q4 2017 | $1,860,000 | -27.6% | 1,200,000 | 0.0% | 0.08% | -28.8% |
| Q3 2017 | $2,568,000 | -52.7% | 1,200,000 | 0.0% | 0.12% | -56.9% |
| Q2 2017 | $5,424,000 | +50.2% | 1,200,000 | 0.0% | 0.27% | +31.7% |
| Q1 2017 | $3,612,000 | +9.1% | 1,200,000 | 0.0% | 0.21% | -6.3% |
| Q4 2016 | $3,312,000 | -11.7% | 1,200,000 | 0.0% | 0.22% | -5.5% |
| Q3 2016 | $3,751,000 | -38.9% | 1,200,000 | 0.0% | 0.24% | -48.4% |
| Q2 2016 | $6,144,000 | +26.2% | 1,200,000 | +0.8% | 0.46% | +11.5% |
| Q1 2016 | $4,867,000 | -49.6% | 1,190,000 | 0.0% | 0.41% | -44.2% |
| Q4 2015 | $9,651,000 | -3.9% | 1,190,000 | 0.0% | 0.73% | -10.3% |
| Q3 2015 | $10,044,000 | +70.8% | 1,190,000 | +90.4% | 0.82% | +90.0% |
| Q2 2015 | $5,881,000 | +12.4% | 625,000 | +10.6% | 0.43% | -12.3% |
| Q1 2015 | $5,232,000 | – | 565,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alistair Capital Management, L.L.C. | 917,400 | $5,715,000 | 2.56% |
| Fortress Investment Group LLC | 2,481,596 | $15,460,000 | 0.24% |
| PERKINS CAPITAL MANAGEMENT INC | 14,000 | $87,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,332,260 | $8,386,000 | 0.02% |
| TFS CAPITAL LLC | 26,116 | $163,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 54,815 | $342,000 | 0.01% |
| Renaissance Technologies | 218,913 | $1,364,000 | 0.00% |
| Alberta Investment Management Corp | 19,140 | $128,000 | 0.00% |
| OAK RIDGE INVESTMENTS LLC | 11,055 | $69,000 | 0.00% |
| SUMMIT SECURITIES GROUP LLC | 600 | $4,000 | 0.00% |